A peptide derived from the highly conserved protein gapdh is involved in tissue protection by different antifungal strategies and epithelial immunomodulation

Journal of Investigative Dermatology

Volumn 133, Issue 1, 2013, Pages 144-153

  Wagener, Jeanette ^a   Schneider, Josef J ^b   Baxmann, Susann ^c   Kalbacher, Hubert ^a   Borelli, Claudia ^b   Nuding, Sabine ^d   Küchler, Robert ^d   Wehkamp, Jan ^d   Kaeser, Matthias D ^e   Mailänder Sanchez, Daniela ^a   Braunsdorf, Christina ^a   Hube, Bernhard ^f,g,h   Schild, Lydia ^f   Forssmann, Wolf Georg ^c   Korting, Hans Christian ^b   Liepke, Cornelia ^c   Schaller, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c IPF PHARMACEUTICALS GMBH   (Germany)

^d DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^e Pevion Biotech AG   (Switzerland)

^f HANS KNÖLL INSTITUTE   (Germany)

^g FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^h Center for Sepsis Control and Care   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; ASPARTIC PROTEINASE 1P; ASPARTIC PROTEINASE 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CELL POPULATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG PURIFICATION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME INHIBITION; FUNGAL CELL; IMMUNOMODULATION; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TISSUE INJURY;

EID: 84872181591     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.254     Document Type: Article

References (31)

1. Barber RD, Harmer DW, Coleman RA et al. (2005) GAPDH as a housekeeping gene: Analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 21:389-955
2. Borelli C, Ruge E, Lee JH et al. (2008) X-ray structures of Sap1 and Sap5: Structural comparison of the secreted aspartic proteinases from Candida albicans. Proteins 72:1308-199
3. Braga-Silva LA, Santos AL (2011) Aspartic protease inhibitors as potential anti- Candida albicans drugs: Impacts on fungal biology, virulence and pathogenesis. Curr Med Chem 18:2401-199
4. Dalle F, Wachtler B, L'Ollivier C et al. (2010) Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol 12:248-711
5. Dumke R, Hausner M, Jacobs E (2011) Role of Mycoplasma pneumoniae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mediating interactions with the human extracellular matrix. Microbiology 157:2328-388
6. Egea L, Aguilera L, Gimenez R et al. (2007) Role of secreted glyceraldehyde- 3-phosphate dehydrogenase in the infection mechanism of enterohemorrhagic and enteropathogenic Escherichia coli: Interaction of the extracellular enzyme with human plasminogen and fibrinogen. Int J Biochem Cell Biol 39:1190-2033
7. Fera MT, La Camera E, De Sarro A (2009) New triazoles and echinocandins: Mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther 7:981-988
8. Gauwerky K, Borelli C, Korting HC (2009) Targeting virulence: A new paradigm for antifungals. Drug Discov Today 14:214-222
9. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-50-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198:179-822
10. Korting HC, Schaller M, Eder G et al. (1999) Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother 43:2038-422
11. Leroy O, Gangneux JP, Montravers P et al. (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37:1612-88
12. Liepke C, Baxmann S, Heine C et al. (2003) Human hemoglobinderived peptides exhibit antimicrobial activity: A class of host defense peptides. J Chromatogr B Analyt Technol Biomed Life Sci 791: 345-566
13. Mookherjee N, Lippert DN, Hamill P et al. (2009) Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol 183: 2688-966
14. Morero RD, Vinals AL, Bloj B et al. (1985) Fusion of phospholipid vesicles induced by muscle glyceraldehyde-3-phosphate dehydrogenase in the absence of calcium. Biochemistry 24:1904-99
15. Nuding S, Fellermann K, Wehkamp J et al. (2006) A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J Microbiol Methods 65:335-455
16. Peman J, Canton E, Espinel-Ingroff A (2009) Antifungal drug resistance mechanisms. Expert Rev Anti Infect Ther 7:453-600
17. Sakamoto N, Mukae H, Fujii T et al. (2005) Differential effects of alphaand beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 288:L508-133
18. Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029-500
19. Schaller M, Borelli C, Korting HC et al. (2005) Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48:365-777
20. Schittek B, Paulmann M, Senyurek I et al. (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8:135-433
21. Schroeder BO, Wu Z, Nuding S et al. (2011) Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 469:419-233
22. Singh R, Green MR (1993) Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259:365-88
23. Sirover MA (1999) New insights into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-844
24. Sirover MA (2011) On the functional diversity of glyceraldehyde-3- phosphate dehydrogenase: Biochemical mechanisms and regulatory control. Biochim Biophys Acta 1810:741-511
25. Tisdale EJ (2001) Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. J Biol Chem 276: 2480-66
26. van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA et al. (2002) Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: Modulation by dexamethasone. Inflamm Res 51:8-155
27. Weindl G, Naglik JR, Kaesler S et al. (2007) Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 117:3664-722
28. Wu T, Samaranayake LP, Leung WK et al. (1999) Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol 48:721-300
29. Yamaji R, Chatani E, Harada N et al. (2005) Glyceraldehyde-3-phosphate dehydrogenase in the extracellular space inhibits cell spreading. Biochim Biophys Acta 1726:261-711
30. Zaidi N, Herrmann T, Baechle D et al. (2007) A new approach for distinguishing cathepsin E and D activity in antigen-processing organelles. FEBS J 274:3138-499
31. Zhu W, Filler SG (2010) Interactions of Candida albicans with epithelial cells. Cell Microbiol 12:273-822